Sentien Biotechnologies, Inc. SBIR Phase II Award, August 2014
A SBIR Phase II contract was awarded to Sentien Biotechnologies in August, 2014 for $2,985,949.0 USD from the U.S. Department of Health & Human Services.
Currently, there are no issues on this topic.
Find more entities like Sentien Biotechnologies, Inc. SBIR Phase II Award, August 2014
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.